Skip to main content
. 2020 Nov 20;112(1):314–322. doi: 10.1111/cas.14693

TABLE 2.

Treatment efficacy of regorafenib in mCRC patients

FLT3 amp status n CR + PR SD PD DCR
Non‐amplification 13 0 3 10 23.0%
Amplification 7 0 4 3 57.1%

Abbreviations: amp, amplification; CR, complete remission; DCR, disease control rate; PD, progressive disease; PR, partial response; SD, stable disease.